Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Christoph Lange, Ibrahim Abubakar, Jan‐Willem C. Alffenaar, et al.
European Respiratory Journal (2014) Vol. 44, Iss. 1, pp. 23-63
Open Access | Times Cited: 290

Showing 1-25 of 290 citing articles:

Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, et al.
European Respiratory Journal (2015) Vol. 45, Iss. 4, pp. 928-952
Open Access | Times Cited: 699
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
The Lancet Respiratory Medicine (2017) Vol. 5, Iss. 4, pp. 291-360
Closed Access | Times Cited: 580
Tuberculosis
Keertan Dheda, Clifton E. Barry, Gary Maartens
The Lancet (2015) Vol. 387, Iss. 10024, pp. 1211-1226
Open Access | Times Cited: 528
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Francesc Coll, Ruth McNerney, Mark D. Preston, et al.
Genome Medicine (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 381
Treatment of Tuberculosis
C. Robert Horsburgh, Clifton E. Barry, Christoph Lange
New England Journal of Medicine (2015) Vol. 373, Iss. 22, pp. 2149-2160
Closed Access | Times Cited: 307
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia
Frederick L. Altice, Lyuba Azbel, Jack Stone, et al.
The Lancet (2016) Vol. 388, Iss. 10050, pp. 1228-1248
Open Access | Times Cited: 252
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
Jakko van Ingen, Timothy R. Aksamit, C. Andréjak, et al.
European Respiratory Journal (2018) Vol. 51, Iss. 3, pp. 1800170-1800170
Open Access | Times Cited: 207
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
Giovanni Battista Migliori, Simon Tiberi, Alimuddin Zumla, et al.
International Journal of Infectious Diseases (2020) Vol. 92, pp. S15-S25
Open Access | Times Cited: 190
Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases
Christoph Lange, Erik C. Böttger, Emmanuelle Cambau, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. e178-e190
Closed Access | Times Cited: 92
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
José Domínguez, Martin J. Boeree, Emmanuelle Cambau, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 4, pp. e122-e137
Closed Access | Times Cited: 57
Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance
Christopher A. Desjardins, Keira A. Cohen, Vanisha Munsamy, et al.
Nature Genetics (2016) Vol. 48, Iss. 5, pp. 544-551
Open Access | Times Cited: 159
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
H. M. Adnan Hameed, Md. Mahmudul Islam, Chiranjibi Chhotaray, et al.
Frontiers in Cellular and Infection Microbiology (2018) Vol. 8
Open Access | Times Cited: 151
Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
Paolo Miotto, Andrea Maurizio Cabibbe, Silke Feuerriegel, et al.
mBio (2014) Vol. 5, Iss. 5
Open Access | Times Cited: 144
Tuberculous pleural effusion
Kan Zhai, Yong Lu, Huan‐Zhong Shi
Journal of Thoracic Disease (2016) Vol. 8, Iss. 7, pp. E486-E494
Open Access | Times Cited: 141
Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges
Gunar Günther
Clinical Medicine (2014) Vol. 14, Iss. 3, pp. 279-285
Open Access | Times Cited: 118
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region
Danila Zimenkov, E. Yu. Nosova, Elena V. Kulagina, et al.
Journal of Antimicrobial Chemotherapy (2017) Vol. 72, Iss. 7, pp. 1901-1906
Open Access | Times Cited: 116
S2k-Leitlinie: Tuberkulose im Erwachsenenalter
Tom Schaberg, Torsten Bauer, Folke Brinkmann, et al.
Pneumologie (2017) Vol. 71, Iss. 06, pp. 325-397
Closed Access | Times Cited: 110
Clinical use of whole genome sequencing for Mycobacterium tuberculosis
Adam A. Witney, Catherine A. Cosgrove, Amber Arnold, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 106
Classification of antituberculosis drugs: a new proposal based on the most recent evidence
José A. Caminero, Anna Scardigli
European Respiratory Journal (2015) Vol. 46, Iss. 4, pp. 887-893
Open Access | Times Cited: 104
Clinical Application of Whole-Genome Sequencing To Inform Treatment for Multidrug-Resistant Tuberculosis Cases
Adam A. Witney, Katherine A. Gould, Amber Arnold, et al.
Journal of Clinical Microbiology (2015) Vol. 53, Iss. 5, pp. 1473-1483
Open Access | Times Cited: 103
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis
Jan Heyckendorf, Sönke Andres, Claudio U. Köser, et al.
Antimicrobial Agents and Chemotherapy (2017) Vol. 62, Iss. 2
Open Access | Times Cited: 97
Multidrug-Resistant Tuberculosis in Europe, 2010–2011
Gunar Günther, Frank van Leth, Sofia Alexandru, et al.
Emerging infectious diseases (2015) Vol. 21, Iss. 3, pp. 409-416
Open Access | Times Cited: 95
Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
Rajendra Prasad, Nikhil Gupta, Amitabh Banka
Lung India (2017) Vol. 35, Iss. 1, pp. 78-78
Open Access | Times Cited: 90
Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains
Carlos A. Guerrero-Bustamante, Rebekah M. Dedrick, Rebecca A. Garlena, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 87
Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
Kefyalew Addis Alene, Archie C. A. Clements, Emma S. McBryde, et al.
Journal of Infection (2018) Vol. 77, Iss. 5, pp. 357-367
Closed Access | Times Cited: 83
Page 1 - Next Page

Scroll to top